Ariad Pharma (ARIA) Posts Wider than Expected Q2 Loss of 31c/Share
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.46 --0%
Financial Fact:
Other income (expense), net: -5.17M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Other income (expense), net: -5.17M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Live Ventures (LIVE) Reports Q3 Loss of $0.34
- Bit Digital (BTBT) Misses Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
